Drawing for VALO

USPTO serial 88945779

VALO

Reviewed by CopyMark Law Group

Reg. 7463688Status 700Registered
Filing date
Status date
Registration date
Jul 30, 2024
Examiner
ADEBAYO, OMOLAYO E.
Law office
TMO LAW OFFICE 100

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VALO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Allison Strickland Ricketts

Allison Strickland Ricketts FROSS ZELNICK LEHRMAN & ZISSU, P.C.151 West 42nd St., 17th FlNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for treatment of cardiovascular diseases and disorders, and therapeutic agents for the treatment of cardiovascular diseases and disordersACTIVEAug 16, 2022
042Pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceutical preparations and substances for use in clinical trials; providing on-line nondownloadable computer software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing on-line non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, biology, biochemistryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 12, 2024PCGRPETITION TO DIRECTOR GRANTED—
Aug 9, 2024APETASSIGNED TO PETITION STAFF—
Aug 9, 2024TPDRTEAS PETITION TO DIRECTOR RECEIVED—
Jul 30, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 30, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 27, 2024SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jun 27, 2024CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 12, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 12, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 12, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 30, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 28, 2024IUAFUSE AMENDMENT FILED—
May 28, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 12, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 11, 2023EX5GSOU EXTENSION 5 GRANTED—
Dec 11, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 1, 2023EXT5SOU EXTENSION 5 FILED—
Dec 1, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 25, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 23, 2023EX4GSOU EXTENSION 4 GRANTED—
Feb 23, 2023EXT4SOU EXTENSION 4 FILED—
Feb 23, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 12, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 10, 2022EX3GSOU EXTENSION 3 GRANTED—
Nov 10, 2022EXT3SOU EXTENSION 3 FILED—
Nov 10, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 10, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 8, 2022EX2GSOU EXTENSION 2 GRANTED—
Jun 8, 2022EXT2SOU EXTENSION 2 FILED—
Jun 8, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 25, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 25, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 25, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 7, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 3, 2021EX1GSOU EXTENSION 1 GRANTED—
Dec 3, 2021EXT1SOU EXTENSION 1 FILED—
Dec 3, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 8, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 26, 2021ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Mar 24, 2021CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Mar 23, 2021APETASSIGNED TO PETITION STAFF—
Jan 21, 2021EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Nov 24, 2020ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 27, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 27, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 14, 2020ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 7, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 18, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 18, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Sep 18, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 18, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 18, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 17, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 16, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 16, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 11, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 4, 2020DOCKASSIGNED TO EXAMINER—
Jun 24, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance